← Open Payments lookup

PETER FORMUSOH: Open Payments

NPI 1114559325 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,380 in 136 payments from 13 companies in 2025. Trend: 2023 $343 · 2024 $1,476 · 2025 $3,380

Food & beverage: $3,375Education: $5
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.44$906
Janssen Pharmaceuticals, Inc29$789
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$417
ABBVIE INC.13$305
E.R. Squibb & Sons, L.L.C.10$268
Otsuka America Pharmaceutical, Inc.6$225
Vanda Pharmaceuticals Inc.9$150
Lundbeck LLC6$142
Axsome Therapeutics, Inc.3$61
Alkermes, Inc.2$46

Products named: INVEGA SUSTENNA, UZEDY, CAPLYTA, REXULTI, VRAYLAR, COBENFY, AUSTEDO XR, FANAPT.

Industry payments across TX — which companies pay providers there.